Patient advocacy organizations (PAOs) are playing a significant role in the drug approval process, leading to debates about the ethics of their influence and calls for greater transparency. The article discusses the three pathways through which PAOs can exert influence, the potential conflict of interest due to industry funding, and the need for transparency in the selection process of patient representatives.
Sep 25, 2023 - biospace.com
